The unusual case of fibroma of tendon sheath in a young girl with turner syndrome undergoing growth hormone treatment

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Fibroma of tendon sheath (FTS) is an uncommon mass that arises from the tendon sheath of extremities. The tumor typically affects adults between ages 20 and 50 years with a predominance in males. To date, growth hormone (GH) treatment is safe for children with Turner syndrome without risk factors and is accepted worldwide. This article reports the case of a nine-year-old female patient with Turner syndrome and FTS during GH treatment. She had been treated with daily subcutaneous GH to improve growth failure with a mean dose of 0.28 mg/kg/week and the level of insulin-like growth factor-1 was within the normal range. During the follow-up period, she complained about a mass in her hand, subsequently diagnosed as FTS. This report illustrates the clinical impact of Turner syndrome and GH treatments on the occurrence of this tumor through literature reviews. Further studies are needed to highlight the association between FTS and GH treatment, especially in Turner syndrome.

Cite

CITATION STYLE

APA

Hong, Y. H., Kim, D. G., Lee, J. H., Jung, M. J., & Choi, C. Y. (2021). The unusual case of fibroma of tendon sheath in a young girl with turner syndrome undergoing growth hormone treatment. JCRPE Journal of Clinical Research in Pediatric Endocrinology, 13(1), 104–108. https://doi.org/10.4274/jcrpe.galenos.2020.2019.0223

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free